Skip to search formSkip to main contentSkip to account menu

REGN421

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Monoclonal Antibodies

Narrower (1)

enoticumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth
Delta-like ligand 4 (Dll4), one of the Notch ligands, is overexpressed in ovarian cancer, especially in tumors resistant to anti… 
2015
2015
Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
The Notch ligand delta-like 4 (Dll4) has been identified as a promising target in tumor angiogenesis in preclinical studies, and… 
2014
2014
Abstract 2993: Dll4 inhibition plus aflibercept markedly reduces ovarian tumor burden and ascites
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Purpose: To determine the effects of Dll4 blockade with… 
2013
2013
Abstract 5091: Potent anti-tumor activity of blocking stromal Dll4 in ovarian xenograft models.
Potent anti-tumor activity of blocking stromal Dll4 in ovarian xenograft models Delta-like ligand 4 (Dll4) is an emerging… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)